Do you need a Washington, DC Benicar lawyer? Contact one of our Washington, DC Benicar lawyers now.
Benicar - News Articles
-
May 13, 2008
PharmaLive.com (press release), PA -
agreement with Glaxo Smith Kline Pharmaceuticals Limited for the antihypertensive agent BenitecTM (generic name: olmesartan medoxomil) in India. Sales of the drug are to start in June 2008. DAIICHI SANKYO established its India subsidiary Daiichi Sankyo India ... -
May 23, 2008
7thSpace Interactive (press release), NY -
Methods: We examined effects of the AT1 antagonist (AT1A) olmesartan medoxomil (olmesartan) and the AT2 antagonist (AT2A) PD-123319 on BLM-induced pulmonary fibrosis, which was evaluated by Ashcroftas pathological scoring and hydroxyproline content of lungs. We also analyzed the ... -
May 16, 2008
Medical News Today (press release), UK -
There has been no long-term use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar effects would be expected with AZOR because of the olmesartan medoxomil component. ... -
May 14, 2008
domain-B, India -
GlaxoSmithKline Pharmaceuticals Ltd has signed a co-production agreement with Japanese drug maker Daiichi Sankyo Company Limited for the latter's ... -
May 14, 2008
Calcutta Telegraph, India -
Mumbai, May 14: GlaxoSmithKline (GSK) Pharma has entered into a co-promotion agreement with Daiichi Sankyo India Pharma Ltd to bring the latter’s ... -
May 14, 2008
TopNews, India -
India’s GlaxoSmithKline (GSK) Pharmaceuticals has informed that it has signed a co-promotion agreement with Daiichi Sankyo India Pharma (DSIN) for the company and is available in more than 50 countries worldwide. GlaxoSmithKline Pharma is a 49 ... -
May 14, 2008
Moneycontrol.com, India -
GlaxoSmithKline (GSK) Pharma has signed a co-promotion agreement with Daiichi Sankyo India Pharma Ltd for anti-hypertensive drug Olmesartan Medoxomil and its combination products. The agreement also marks Daiichi Sankyo India Pharma?s entry into India. ... -
May 13, 2008
Reuters -
MUMBAI, May 14 (Reuters) - India's GlaxoSmithKline Pharmaceuticals Ltd (GLAX.BO: Quote, Profile, Research) said on Wednesday it had signed a co-production agreement with Japanese drug maker Daiichi Sankyo (4568.T: Quote, Profile, Research) for..."; ... -
May 14, 2008
Hindu, India -
Mumbai (PTI): Pharmaceutical firm GlaxoSmithKline (GSK) Pharma on Wednesday said it has entered into an agreement with Daiichi Sankyo India Pharma Limited (DSIPL) for jointly promoting the anti-hypertensive drug Olmesartan Medoxomil and its combination products. GSK India has ... -
May 14, 2008
Forbes, NY -
MUMBAI (Thomson Financial) - GlaxoSmithKline Pharmaceuticals Ltd., an India-based 49 pct subsidiary of British drugmaker GlaxoSmithKline Plc., ...
-
May 14, 2008
Business Standard, India -
GlaxoSmithKline (GSK) Pharma, the Indian arm of global drug major GlaxoSmithKline Plc, has signed a co-promotion agreement with Daiichi Sankyo India Pharma Limited (DSIN), the Indian subsidiary of Japanese pharmaceuticals major Daiichi Sankyo Company Limited, to market an anti-hypertension drug and ... -
May 14, 2008
Business Standard, India -
GlaxoSmithKline (GSK) Pharmaceuticals, the Indian arm of global drug manufacturer GlaxoSmithKline, has signed an agreement with Daiichi Sankyo India Pharma . The $8-billion Daiichi Sankyo, Japan's second largest pharma company, recently set up its subsidiary in India ... -
May 12, 2008
Trading Markets (press release), CA -
TOKYO, May 13, 2008 (Thomson Financial via COMTEX) -- DSKYF | news | PowerRating | PR Charts -- Japanese pharmaceutical company Daiichi Sankyo Co., Ltd. said Tuesday its net profit grew 24.3 percent in the year ended March on brisk sales of its ... -
May 12, 2008
ITNews, Italy -
DAIICHI SANKYO, one of the world's leading research-driven pharmaceutical companies based in Japan, is establishing its own subsidiary in Turkey. The company, to be called DAIICHI SANKYO Ilaç Tikaret Ltd., will be headquartered in Istanbul and will initially focus ... -
May 13, 2008
Japan Corporate News (press release), Japan -
Tokyo, May 13, 2008 (Jiji Press) - Japanese drug maker Daiichi Sankyo Co. <4568> said Tuesday it has established a unit in Istanbul, Turkey, to boost sales of its drugs. Daiichi Sankyo Ilac, Tiaret Ltd., a subsidiary of Daiichi Sankyo Europe GmbH., will mainly ... -
May 14, 2008
Pharma Times (subscription), UK -
Daiichi Sankyo has posted a healthy rise in annual earnings but says that its plans for expansion outside Japan and increased R&D costs will hit profits ... -
May 12, 2008
Bloomberg -
By Kanoko Matsuyama May 13 (Bloomberg) -- Daiichi Sankyo Co., Japan's third- largest drugmaker, had a 44 percent jump in quarterly net income, led by higher ... -
May 12, 2008
Reuters -
TOKYO, May 13 (Reuters) - Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T: Quote, Profile, Research) said on Tuesday one of the main reasons its earnings have fallen short of analysts' estimates in the last business year and the current year was..."; ... -
May 13, 2008
Reuters -
TOKYO (Reuters) - Japanese drug maker Daiichi Sankyo Co Ltd (4568.T: Quote, Profile, Research) booked a 15 percent rise in annual operating profit on Tuesday but forecast a surprise sharp drop in earnings for the current year on higher R&D costs and expansion ... -
May 13, 2008
Reuters -
By Edwina Gibbs TOKYO (Reuters) - Japanese drug makers Daiichi Sankyo Co Ltd (4568.T: Quote, Profile, Research) and Astellas Pharma Inc (4503. T: Quote , Profile , Research ) booked rises in annual operating profit on Tuesday but forecast ...
Do you need a Washington, DC Benicar lawyer? Contact one of our Washington, DC Benicar lawyers now.
Pages: 1 2 3 4 5 6 ... Next
These articles are related to: Benicar Claim, Benicar Lawsuit, Benicar Law Suit, Benicar Law Firm, Benicar Lawyer, Benicar Attorney, Benicar Side Effects Symptoms, Benicar Trial, Benicar Verdict, Benicar News, Benicar Information, Benicar Recall Lawyers, Benicar Warning, Benicar Class Action, Benicar Prescription Drug, Benicar Medication, Benicar Drugs, Olmesartan Medoxomil Claim, Olmesartan Medoxomil Lawsuit, Olmesartan Medoxomil Law Suit, Olmesartan Medoxomil Law Firm, Olmesartan Medoxomil Lawyer, Olmesartan Medoxomil Attorney, Olmesartan Medoxomil Side Effects Symptoms, Olmesartan Medoxomil Trial, Olmesartan Medoxomil Verdict, Olmesartan Medoxomil News, Olmesartan Medoxomil Information, Olmesartan Medoxomil Recall Lawyers, Olmesartan Medoxomil Warning, Olmesartan Medoxomil Class Action, Olmesartan Medoxomil Prescription Drug, Olmesartan Medoxomil Medication, Olmesartan Medoxomil Drugs
